Search Results - "Caporalini, C."

Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series by Caporalini, C., Scagnet, M., Giunti, L., Cetica, V., Mei, D., Conti, V., Moscardi, S., Macconi, L., Giordano, F., D'Incerti, L., Genitori, L., Guerrini, R., Buccoliero, A.M.

“…Myxoid glioneuronal tumor (MGT) is a benign glioneuronal neoplasm recently introduced in the World Health Organization (WHO) classification of the central…”
Get full text

Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature by Ghilli, M., Mariniello, M. D., Scatena, C., Dosa, l., Traficante, G., Tamburini, A., Caporalini, C., Buccoliero, A. M., Facchini, F., Colizzi, L., Quattrini Li, A., Landucci, E., Manca, G., Naccarato, A. G., Caramella, D., Favre, C., Roncella, M.

“…Purpose Secretory breast cancer (SBC) is one of the rarest breast cancer (BC), representing the majority of BC in childhood. Nevertheless, it elicits a lot of…”
Get full text

P07.03.A COMPLETE LONG-LASTING RESPONSE TO MULTIMODAL THIRD LINE TREATMENT WITH NEUROSURGICAL RESECTION, CARMUSTINE WAFER IMPLANTATION AND DABRAFENIB PLUS TRAMETINIB IN A BRAFV600E MUTATED HIGH-GRADE GLIOMA by Fonte, C, Castelli, B, Tellini, M, Guidi, M, Giunti, L, Di Nicola, M, Buccoliero, A, Caporalini, C, Desideri, I, Greto, D, Genitori, L, Sardi, I

“…Abstract BACKGROUND BRAF mutations are drivers of oncogenesis in a variety of tumors and they can be successfully targeted with small molecule inhibitors. In…”
Get full text

P04.01.B MEK INHIBITORS IN PEDIATRIC RECURRENT SYMPTOMATIC UNRESECTABLE LOW-GRADE GLIOMAS HARBORING MAPK ALTERATION: A SINGLE CENTER EXPERIENCE by Fonte, C, Castelli, B, Tellini, M, Guidi, M, Giunti, L, Di Nicola, M, Buccoliero, A, Caporalini, C, Giordano, F, Mussa, F, Genitori, L, Sardi, I

“…Abstract BACKGROUND Treatment of inoperable, recurrent, progressive pediatric low-grade gliomas (pLGGs) remains controversial. Recent studies focused on…”
Get full text

P16.03.A GEMOX ADD-ON AFTER THE ITALIAN INDUCTION CHEMOTHERAPY SCHEME IN MALIGNANT BRAIN TUMORS UNDER 3 YEARS by Castelli, B, Fonte, C, Tellini, M, Di Nicola, M, Guidi, M, Giunti, L, Marzano, C, Tirinnanzi, B, La Torre, C E, Buccoliero, A M, Caporalini, C, Giordano, F, Tintori, V, D’Incerti, L, Scagnet, M, Genitori, L, Sardi, I

“…Abstract BACKGROUND Gemcitabine plus oxaliplatin chemotherapy (GemOx) represents a possible option in advanced hepatocholangiocarcinoma and pancreatic cancer…”
Get full text

PO-1417 Impact of preoperative radiotherapy in surgically treated Ewing Sarcoma by Ganovelli, M., Frosini, G., Loi, M., Greto, D., Guerrieri, B., Mattioli, C., Cerbai, C., Lorenzetti, V., Campanacci, D.A., Caporalini, C., Muratori, F., Scoccianti, G., Mangoni, M., Livi, L.

Get full text

P04.06.A A PHASE II MONOCENTRIC STUDY OF LIMITED USE OF HIGH DOSE OF CHEMOTHERAPY AND PROTON THERAPY IN PEDIATRIC HIGH RISK MEDULLOBLASTOMA AND OTHER EMBRYONAL CANCERS by Guidi, M, Fonte, C, Tellini, M, Castelli, B, Gori, C G, Giunti, L, Di Nicola, M, Buccoliero, A M, Caporalini, C, Giordano, F, Rombi, B, Desideri, I, Pugi, A, Tortora, K, Greto, D, Genitori, L, Leo, M, Sardi, I

“…Abstract BACKGROUND Despite the multimodal approach, medulloblastoma remains a leading cause of cancer-related death in children. We proposed the preliminary…”
Get full text

P04.05.B ADJUVANT DOXORUBICIN AS ADD-ON THERAPY IN PEDIATRIC MALIGNANT GLIOMAS: A SINGLE-ARM OPEN-LABEL PHASE 2 INTERVENTIONAL STUDY by Tellini, M, Castelli, B, Fonte, C, Guidi, M, Giunti, L, Di Nicola, M, Buccoliero, A M, Caporalini, C, Giordano, F, Desideri, I, Greto, D, Tortora, K, Pugi, A, Genitori, L, Sardi, I

“…Abstract BACKGROUND Pediatric high grade gliomas (pHGGs) are leading causes of tumor related death in pediatric age. Beyond surgical and radiotherapy backbone…”
Get full text

81P Soft tissue solitary fibrous tumor: Analysis of a single center series with a comparison between three prognostic scores by Scoccianti, G., Palomba, A., Caporalini, C., Nozzoli, F., Scanferla, R., Scolari, F., Pillozzi, S., Campanacci, D.A.

Get full text

P05.46 Metachronous malignancies and brain tumor in children with germline TP53 mutation by Guidi, M, Giunti, L, Buccoliero, A, Farina, S, Fonte, C, Caporalini, C, Moscheo, C, Censullo, M, Genitori, L, Sardi, I

“…Abstract Background Somatic TP53 mutations have been reported to occur in almost every type of cancer. They are common alterations in brain tumors…”
Get full text

P01.044 Impact of the addition of vinorelbine to temozolomide in the first-line treatment of pediatric high grade gliomas by Guidi, M, Lucchesi, M, Buccoliero, A, Scoccianti, S, Farina, S, Fonte, C, Caporalini, C, Moscheo, C, Genitori, L, Sardi, I

“…Abstract Background Pediatric high-grade gliomas (HGGs) are comprised primarily of anaplastic astrocytomas (AA, WHO-grade III) and glioblastomas (GBM,…”
Get full text